Merck & Co Inc
Groundbreaking Lung Cancer Drug Reduces Death Risk by 34% in Controversial Late-Stage Trial in China
An experimental lung cancer drug called ivonescimab, developed by Akeso and Summit Therapeutics, has shown promise in clinical trials. Recent ... Read more
Jim Cramer Explains How Dell’s Impressive Quarter Paves the Way for a Critical Week in AI Stocks
Jim Cramer from CNBC recently shared insights on technology stocks, particularly in light of Dell Technologies’ impressive quarterly results. Cramer ... Read more
Live Updates: S&P 500 Futures Surge as ‘Mag 7’ Giants Alphabet and Amazon Release Earnings
Traders on the New York Stock Exchange had a busy day, especially with big tech companies releasing quarterly earnings. S&P ... Read more
Unlock Savings: Everything You Need to Know About Trump Rx, the White House’s New Direct-to-Consumer Drug Portal
President Trump will soon unveil TrumpRx, a new website aimed at lowering prescription drug costs for Americans. This initiative focuses ... Read more
Top Premarket Movers: Palantir, Merck, Pfizer, and More Stocks to Watch Today
Sure! Here’s a simplified and engaging rewrite of the content: Stock Market Highlights: Key Movers Today Here’s a look at ... Read more
S&P 500 Futures Climb on Strong Earnings: Get Live Updates Ahead of the Fed Decision!
Stock futures are looking positive following strong corporate earnings. The S&P 500 and Nasdaq Composite both reached new highs recently, ... Read more
